FDA Investigator Jane M Kreis

Jane M Kreis has conducted inspections on 76 sites in 4 countries as of 29 Jun 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
76
Last Inspection Date:
29 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
100000615
Countries of Inspections:
India, United States of America, Argentina, Canada
FDA Investigators that have inspected at least one site in common with Jane M Kreis:
Abby M Miller, Alan D Grupe, Alanna L Mussawwir Bias, Alexander M Kay, Alicia Aborg Borm, Amanda E Lewin, PhD, Amy R Glynn, Andrew R Wasko, Anita Narula, PhD, Anthony E Keller, RPh, Arindam Dasgupta, PhD, Astrida B Mattson, Avery J Dennis, Barbara Janine Breithaupt, Brenda K Alford, Bruce R Burrell, Camille Bennett Hoffman, Carl A Anderson, Carl Lee, Caryn M Mcnab, Ce'nedra M Martin, Celia L Hutchinstein, Charles D Brown, Charles R Bonapace, PhD, Christopher R Czajka, Connie P Rezendes, Courtney N Long, Crystal A Harlan, Ct Viswanathan, PhD, Cynthia L Gorveatt, Daniel L Aisen, Darlene B Almogela, Dawn E Barkans, Deborah A Nebenzahl, Dennis R Hudson, Diane Cvan Leeuwen, Dirk L Lincoln, Dolores E Price, Donald B Mckechnie, Donald W Jehn, Douglas J Scott, Dov H Pluznik, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dylan D Yao, MD, PhD, Eric C Milstead, Erin M Mcdowell, Geoffrey K Kilili, Gerard Pde Leon, Gilbert T Salud, Gloria J Baca, MS, Grace P Santos, Hanna L Potter, Heika R Bounds, Heika R Tait, Henry K Lau, Hugh A Grimoldby, Hugh M Mcclure, II, Humberto Z Gomez, Jacqueline A O'shaughnessy, PhD, James C Henry, James E Trabert, Janete F Guardia, Jean Brewer, Jeanne M Weishaar, Jeffrey W Shrifter, DPM, Jennifer C Adams, Jessie J Deloach, Jinkee Mvila Binayug, John W Banks, Jonathan T Little, Joshua S Hunt, Joy P Matthias, Julian C Hanson, June H Wetherington, Jyoti B Patel, PhD, Katherine L Arnold, Kathryn A Krentz, Keegan B Mixon, Kelsey A Hustedt, Kelsey A Volkman, Kevin P Foley, Kevin T Gerrity, Kimberly Jproctor Jones, Lance Mde Souza, MBA, Lance W Bohm, Lawrence Y Lee, PhD, LCDR Ismael Olvera, IV, Leonard H Lavi, Leya A Grosch, Linda S Leja, Lisa K Capron, Lori J Silverstein, Makini Cobourne Duval, PhD, Margo C Jones, Maria Pkelly Doggett, MBA, Marie K Kinkade, Marijo B Kambere, PhD, Mark E Imsland, Mark E Moen, Mark W Babbitt, Matthew C Watson, Melody M Ragasa Leong, Michael F Schuette, Michael F Skelly, PhD, Michael J Donovan, Michael S Valenzuela, Michelle M Moore, Minh D Phan, Nancy A Saxenian Emmons, Nancy E Byerly, Neil J Traaen, Paul M Kawamoto, Paula A Trost, Paula J Bretz, Prabhu P Raju, Rachel C Harrington, Rebecca A Sletner, Rebecca T Davis, Richard G Runyon, Robert A Williams, Robert D Tollefsen, Rocco C Black, Roger J Adams, Ronald E Gill, S Lori Brown, PhD MPH, Shannon J Hall, Sharon I Gundersen, Shelagh D Schopen, Shelley H Beausoleil, Sherri N Rohlf, MD, Sripal R Mada, PhD, Stanley B Eugene, BS, BME, Stuart W Russell, Sunitha K Rajaram, PhD, Susanne M Richardson, MS RAC, Tara M Pianko, Thea C Grome, Thomas C Mclean, CFS, Thomas W Gordon, Timothy C Grome, Tracy K Li, Uduak M Inokon, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Veronica L Bush, Xiaojun Yan, Xikui Chen (nmi), PhD, Young M Choi, PhD

Jane M Kreis's Documents

Publish Date Document Type Title
March, 2003 EIR Alan F. Barker, MD - EIR, 2003-03-06
March, 2004 FDA 483 June Hawkins, MD - Form 483, 2004-03-04
September, 2015 EIR Surpass - Silicon Valley, LLC - EIR, 2015-09-18
August, 2002 FDA 483 Western Institutional Review Board, Inc. - Form 483, 2002-08-23
December, 2012 FDA 483 FVS Holdings, Inc. dba. Green Valley Drugs - Form 483, 2012-12-20
November, 2009 FDA 483 CTI Biopharma Corp - Form 483, 2009-11-18
September, 2015 FDA 483 Ekso Bionics - Form 483, 2015-09-11
August, 2003 EIR Integra Chemical Company - EIR, 2003-08-12
October, 2003 EIR Nitrox, Inc. - EIR, 2003-10-28
March, 2003 FDA 483 Alan F. Barker, MD - Form 483, 2003-03-06
November, 2003 FDA 483 Response Magno-Humphries, Inc. - Form 483R, 2004-01-23
August, 2002 FDA 483 Response WCG IRB, Inc - Form 483R, 2002-09-19
April, 2004 EIR Altasciences Preclinical Seattle, LLC - EIR, 2004-04-26
January, 2004 FDA 483 Great Scott Skin Care Products, LLC - Form 483, 2004-01-30
February, 2003 FDA 483 Arifulla Khan MD - Form 483, 2003-02-19
August, 2003 EIR Battelle Pacific Northwest Lab - EIR, 2003-08-01
November, 2003 FDA 483 Magno-Humphries, Inc. - Form 483, 2003-11-21
January, 2005 EIR Immunex Corp. - EIR, 2005-01-20
April, 2003 FDA 483 Response MDS Pharma Services - Form 483R, 2003-05-08
March, 2004 EIR June Hawkins, MD - EIR, 2004-03-04
August, 2003 FDA 483 Integra Chemical Company - Form 483, 2003-08-12
May, 2004 EIR Bensinger, William I. M.D. - EIR, 2004-05-27
April, 2003 EIR MDS Pharma Services - EIR, 2003-04-22
April, 2015 EIR International Cellular Medicine Society IRB - EIR, 2015-04-17
August, 2002 EIR WCG IRB, Inc - EIR, 2002-08-23
December, 2002 FDA 483 University of Washington - Form 483, 2002-12-24
March, 2003 FDA 483 Response Alan F. Barker, MD - Form 483R, 2003-04-10
December, 2002 EIR Chesnut, Charles III, MD - EIR, 2002-12-24
February, 2003 EIR Arifulla Khan MD - EIR, 2003-02-19
February, 2003 FDA 483 Response Arifulla Khan MD - Form 483R, 2003-02-19
May, 2004 FDA 483 Bensinger, William I. M.D. - Form 483, 2004-05-27
April, 2003 FDA 483 MDS Pharma Services - Form 483, 2003-04-22
October, 2003 FDA 483 Nitrox, Inc. - Form 483, 2003-10-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more